Product image of Kartesada (Pregabalin) supplied by GNH India

Kartesada

Active Ingredient:
Pregabalin
Origin:
EU

Kartesada (Pregabalin)

Pregabalin, the active ingredient in Kartesada, is an anticonvulsant presented as an oral formulation for oral use. It is prescribed to manage neuropathic pain, partial onset seizures, and generalized anxiety disorder in adult patients. The medication works by modulating calcium channel activity, which helps reduce abnormal neuronal firing associated with these conditions.

GNH India supplies Kartesada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Manufacturer / TM Owner

Neuraxpharm Bohemia S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pregabalin is used to treat several neurological and pain‑related conditions by modulating calcium channel activity.

  • Diabetic peripheral neuropathic pain: reduces pain intensity and improves functional outcomes.
  • Postherpetic neuralgia: alleviates burning and stabbing pain after shingles.
  • Fibromyalgia: decreases widespread musculoskeletal pain and fatigue.
  • Partial onset seizures: helps control focal seizure activity.
  • Generalized anxiety disorder: lessens excessive worry and tension.

How It Works

  • Pregabalin binds selectively to the α2‑δ subunit of voltage‑gated calcium channels in the central nervous system. This binding reduces calcium influx into presynaptic neurons, which in turn diminishes the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P, leading to decreased neuronal hyperexcitability and pain signaling.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Somnolence: increased sleepiness or fatigue.
  • Peripheral edema: swelling of the lower limbs.
  • Weight gain: gradual increase in body weight.
  • Blurred vision: temporary visual disturbances.
  • Dry mouth: reduced salivation.

Serious or Rare Side Effects

  • Angioedema: rapid swelling of face, lips, or throat.
  • Severe rash or Stevens‑Johnson syndrome: extensive skin reactions.
  • Suicidal thoughts or behavior: emergence of depressive symptoms.
  • Respiratory depression: slowed breathing, especially with CNS depressants.
  • Hypersensitivity reactions: anaphylaxis or severe allergic response.
  • Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.

Precautions & Warnings

Pregabalin requires careful clinical monitoring to ensure safe use.

  • Assess renal function: dose may need adjustment in patients with impaired clearance.
  • Monitor mood changes: watch for depression, anxiety escalation, or suicidal ideation.
  • Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms.
  • Use caution in elderly: increased sensitivity to central nervous system effects.
  • Pregnancy and lactation: risk unknown; prescribe only if benefit outweighs potential risk.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Pregabalin can interact with other medicines, affecting safety and efficacy.

Major Interactions (Avoid)

  • Opioids: additive central nervous system depression may cause profound sedation.
  • Alcohol: combined use can increase drowsiness and impair coordination.
  • ACE inhibitors: may raise the risk of angioedema.

Moderate Interactions (Monitor Closely)

  • Diuretics: may exacerbate peripheral edema.
  • Antihypertensives: potential for enhanced hypotensive effect.
  • Other antiepileptics: may alter seizure control or increase side‑effect burden.

Frequently Asked Questions

Kartesada, which contains pregabalin, is prescribed for diabetic peripheral neuropathic pain, postherpetic neuralgia, fibromyalgia, partial onset seizures, and generalized anxiety disorder. It helps reduce pain, control seizure activity, and lessen anxiety symptoms in adult patients.

Pregabalin binds to the α2‑δ subunit of voltage‑gated calcium channels in the central nervous system. This reduces calcium entry into nerve terminals, decreasing the release of excitatory neurotransmitters and thereby dampening abnormal neuronal firing that contributes to pain, seizures, and anxiety.

The appropriate dose of Kartesada is determined by the prescribing healthcare professional based on the specific indication, patient characteristics, and renal function. Dosage adjustments are individualized, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for pregabalin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To order Kartesada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kartesada (pregabalin) is an anticonvulsant that targets calcium channels, whereas alternatives such as duloxetine act on serotonin‑norepinephrine reuptake. Clinical studies show pregabalin provides rapid pain relief, but individual response varies, and choice of therapy depends on efficacy, tolerability, comorbidities and physician judgment.

Store Kartesada at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Kartesada is taken orally, usually with or without food, as directed by the prescriber. The tablets (or capsules) should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious risks include the potential for suicidal thoughts or behavior, angioedema, severe skin reactions such as Stevens‑Johnson syndrome, respiratory depression when combined with other CNS depressants, and rare blood disorders. Patients should seek immediate medical attention if any of these occur.

Kartesada is contraindicated in patients with known hypersensitivity to pregabalin or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled heart failure, or those taking interacting CNS depressants without close monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.